Four Ambarella insiders, including CEO Feng-Ming Wang and CFO John Young, sold a combined 14,114 shares at $64.83 on the same day.
Four insiders at Ambarella (AMBA) sold shares on the open market on 17 September 2026, all at the same price of $64.83 per share, according to Form 4 filings submitted the following day. The combined value of the transactions was roughly $915,011.
Tadaa Technology will supply the AI backbone for a 1,000-acre solar farm feeding a data centre under a 25-year power arrangement, targeting $7.3M in annual revenue.
Alpha Compute has signed definitive agreements for Utica and Marcellus acreage with more than 75 wells, and plans to build a data center on the site.
Palisade Bio can start the Phase 2 ASCENTRA-CD trial of its oral PDE4 prodrug, with first dosing targeted for Q1 2027 and a primary readout in Q1 2028.
VERSATILE-002 results for PDS0101 plus pembrolizumab show 39.3 months median overall survival in checkpoint-inhibitor-naive HPV16-positive head and neck cancer.
